Vaccine expert advises: Immunization should be given as early in life as possible

Sep 15, 2009

Parents should not be worried, that early vaccination would overwhelm their babies. Recent data show, that the immune system of newborns is able to respond to a world full of antigens already at birth. Therefore, vaccines should be given as early in life as possible to minimize the risk of damage by a potentially harmful infection, says Prof. Dr. Claire-Anne Siegrist, Head of the Center for Vaccinology and Neonatal Immunology, University of Geneva, at the 2nd European Congress of Immunology ECI 2009.

Many parents would prefer to postpone the vaccination of their babies until these are older, by fear that their young immune system would be too weak or overwhelmed by the vaccines. In contrast, pediatricians insist that babies should be immunized as rapidly as possible after birth against the most dreadful causing or whooping cough. These infections can cause irreversible damage or even kill the children.

During their first three months in life, are protected by antibodies from their mothers’ blood. There is a lack of protection between three months and 24 months, when the immune systeme is fully developed. During this time, the children are extremely susceptible for infections, which indicate the urgent need for an early immunization.

Recent work has demonstrated that the neonatal immune system is indeed well equipped to avoid harmful inflammatory responses while responding very well to specific stimulations such as that provided by immunization. Remarkably, infants vaccinated in presence of maternal antibodies raise excellent cellular immune responses, which are not transmitted from mothers to babies and contribute to protection. “Vaccine antibody responses are weaker in infants than later in life, which represents a challenge that vaccines have to overcome”, says Siegrist. “But these are not limitations but a fine tuning, such that any excessive stimulation may not overwhelm even an immature immune system.”

Immune memory may be elicited already at birth, helping to react quickly when they encounter an aggressive microbe after the protection by is over. Thus, parents need not to worry: Nature has ensured that the neonatal is specifically adapted to respond to a world full of antigens and immunizations may indeed be given as early in life as possible.

Source: German Society for Immunology

Explore further: Acne pill benefits outweigh blood clot risk: EU agency

add to favorites email to friend print save as pdf

Related Stories

Boosting Newborns' Immune Responses

Jun 13, 2009

Newborn babies have immature immune systems, making them highly vulnerable to severe infections and unable to mount an effective immune response to most vaccines, thereby frustrating efforts to protect them. ...

HIV-infected infants respond poorly to childhood vaccination

Dec 05, 2007

It is known that HIV-infected children who do not receive appropriate antiretroviral drugs experience immune depression, and may become susceptible to infectious diseases that would otherwise be prevented by childhood immunization. ...

Recommended for you

First influenza vaccine brought to clinical testing

15 hours ago

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...

Aspirin not always best treatment for many individuals

May 16, 2013

(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as ...

FDA: lower ambien's dose to prevent drowsy driving

May 15, 2013

(HealthDay)—The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard ...

Simponi approved for ulcerative colitis

May 15, 2013

(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.

FDA approves genetic test for lung cancer drug

May 14, 2013

The Food and Drug Administration says it approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by Genentech.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

Sepp
1 / 5 (2) Sep 15, 2009
The immune system of kids may be able to "respond to a world full of antigens", but it is not certainly able to cope with poisonous substances added to vaccines as "adjuvants" such as mercury, alluminium, formaldehyde and other highly toxic stuff.

Wonder if the vaccine expert ever considered the other ingredients in what is being injected into children these days.

More news stories

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Front-row seats to climate change

By day, insects provide the white noise of the South, but the night belongs to the amphibians. In a typical year, the Southern air hangs heavy from the humidity and the sounds of wildlife.

Attacking MRSA with metals from antibacterial clays

In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance.